HESTERBIO — Hester Biosciences Share Price
0.000.00%
Last trade - 00:00- IN₹21.87bn
- IN₹24.11bn
- IN₹3.05bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.56 | ||
| Price to Tang. Book | 7.67 | ||
| Price to Free Cashflow | 92.99 | ||
| Price to Sales | 7.25 | ||
| EV to EBITDA | 41.73 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.38% | ||
| Return on Equity | 6.61% | ||
| Operating Margin | 13.49% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 1,832.68 | 2,143.32 | 2,350.06 | 2,660.91 | 3,045.46 | 3,394 | n/a | 11.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -30.74 | +27.38 | +5.98 | -39.52 | -24.61 | +186.69 | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hester Biosciences Limited is an India-based animal healthcare company. The Company is engaged in providing vaccines, health products and diagnostic laboratory services. The Company operates through four segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Poultry Healthcare products include Gumboro I, Gumboro I +, Inactivated Chick ND, Inactivated Coryza, Inactivated Coryza+, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, Inactivated IB+, Inactivated IB-H52, Inactivated IBD, Inactivated IBD ND, Inactivated IBD ND EDS, Inactivated ND IB, Inactivated Pullet ND, Live B1, Live B1 M48, Live FP, Live H120, Live Las, Live Las Mas, Live M48, Live R2B, Live S-One, MD-Bivalent HVT+SB1, MD-HVT (FD), and Thermostable ND. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Hestaflam Tablet and Hestaliv.
Directors
- Bhupendra Gandhi NEC (71)
- Rajiv Gandhi CEO (52)
- Sahil Shah CFO
- Vinod Mali CCO
- Rahul Srivastava VBD
- Ravin Gandhi NED (41)
- Sanjiv Gandhi NED (49)
- Grishma Nanavaty IND
- Vimal Ambani NID (52)
- Naman Patel NID
- Vishwesh Patel NID (37)
- Amit Shukla NID
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- April 29th, 1987
- Public Since
- August 17th, 1994
- No. of Employees
- 693
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 8,506,865
- Address
- Pushpak 1st Floor, AHMEDABAD, 380006
- Web
- https://www.hester.in/
- Phone
- +91 7926445107
- Auditors
- Chandulal M. Shah & Co.
Upcoming Events for HESTERBIO
Hester Biosciences Ltd Annual Shareholders Meeting
Q2 2025 Hester Biosciences Ltd Earnings Release
Similar to HESTERBIO
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Hester Biosciences share price?
As of Today at 15:07 UTC, shares in Hester Biosciences are trading at IN₹2,594.60. This share price information is delayed by 15 minutes.
How has the Hester Biosciences share price performed this year?
Shares in Hester Biosciences last closed at IN₹2,594.60 and the price had moved by +55.07% over the past 365 days. In terms of relative price strength the Hester Biosciences share price has outperformed the S&P BSE 100 Index by +18.49% over the past year.
What are the analyst and broker recommendations for Hester Biosciences?
The overall consensus recommendation for Hester Biosciences is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Hester Biosciences dividend yield?
The Hester Biosciences dividend yield is 0.23% based on the trailing twelve month period.
Does Hester Biosciences pay a dividend?
Last year, Hester Biosciences paid a total dividend of IN₹6.00, and it currently has a trailing dividend yield of 0.23%. We do not have any data on when Hester Biosciences is to next pay dividends.
When does Hester Biosciences next pay dividends?
We do not have data on when Hester Biosciences is to next pay dividends. The historic dividend yield on Hester Biosciences shares is currently 0.23%.
How do I buy Hester Biosciences shares?
To buy shares in Hester Biosciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hester Biosciences?
As of the previous close price of IN₹2,594.60, shares in Hester Biosciences had a market capitalisation of IN₹22.07bn.
Where are Hester Biosciences shares listed?
Here are the trading details for Hester Biosciences:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: HESTERBIO
What kind of share is Hester Biosciences?
Based on an overall assessment of its quality, value and momentum Hester Biosciences is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hester Biosciences share price forecast for 2024?
The analyst consensus target price for shares in Hester Biosciences is IN₹1,830.00. That is 29.47% below the last closing price of IN₹2,594.60.
Analysts covering Hester Biosciences currently have a consensus Earnings Per Share (EPS) forecast of IN₹59.80 for the next financial year.
What is the trend in the Hester Biosciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hester Biosciences. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +59.93%.
As of the last closing price of IN₹2,594.60, shares in Hester Biosciences were trading +62.04% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hester Biosciences PE Ratio?
The Hester Biosciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹2,594.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hester Biosciences?
Hester Biosciences' management team is headed by:
- Bhupendra Gandhi - NEC
- Rajiv Gandhi - CEO
- Sahil Shah - CFO
- Vinod Mali - CCO
- Rahul Srivastava - VBD
- Ravin Gandhi - NED
- Sanjiv Gandhi - NED
- Grishma Nanavaty - IND
- Vimal Ambani - NID
- Naman Patel - NID
- Vishwesh Patel - NID
- Amit Shukla - NID